145 related articles for article (PubMed ID: 37490778)
1. PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE.
Miki M; Miyata M; Ooto S; Tamura H; Ueda-Arakawa N; Muraoka Y; Miyake M; Hata M; Takahashi A; Kido A; Kogo T; Uji A; Tsujikawa A
Retina; 2023 Nov; 43(11):1971-1979. PubMed ID: 37490778
[TBL] [Abstract][Full Text] [Related]
2. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.
Caporossi T; Bacherini D; Governatori L; Oliverio L; Di Leo L; Tartaro R; Rizzo S
Acta Ophthalmol; 2022 Aug; 100(5):e1143-e1152. PubMed ID: 34609787
[TBL] [Abstract][Full Text] [Related]
3. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
[TBL] [Abstract][Full Text] [Related]
5. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
Tranos P; Tsiropoulos GN; Koronis S; Vakalis A; Asteriadis S; Stavrakas P
Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
[TBL] [Abstract][Full Text] [Related]
6. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator.
Ogata M; Oh H; Nakata A; Doi A; Nakayama H; Hasegawa M; Hirose M
Sci Rep; 2022 Dec; 12(1):22139. PubMed ID: 36550175
[TBL] [Abstract][Full Text] [Related]
7. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH
Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
Kimura S; Morizane Y; Hosokawa MM; Shiode Y; Doi S; Hosogi M; Fujiwara A; Okanouchi T; Inoue Y; Shiraga F
Jpn J Ophthalmol; 2019 Sep; 63(5):382-388. PubMed ID: 31243593
[TBL] [Abstract][Full Text] [Related]
9. VITRECTOMY WITH SUBRETINAL INJECTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE WITH OR WITHOUT VITREOUS HEMORRHAGE.
Shi T; Wen J; Xia H; Chen H
Retina; 2024 Jul; 44(7):1188-1195. PubMed ID: 38452260
[TBL] [Abstract][Full Text] [Related]
10. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
Szeto SKH; Tsang CW; Mohamed S; Lee GKY; Lok JKH; Hui VWK; Tsang KK; Chen LJ; Brelen M; Lai TYY
Ophthalmologica; 2024; 247(2):118-132. PubMed ID: 38408445
[TBL] [Abstract][Full Text] [Related]
11. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
Inoue M; Shiraga F; Shirakata Y; Morizane Y; Kimura S; Hirakata A
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1663-9. PubMed ID: 25418034
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of submacular hemorrhage: experience at an academic Canadian centre.
Juncal VR; Hanout M; Altomare F; Chow DR; Giavedoni LR; Muni RH; Wong DT; Berger AR
Can J Ophthalmol; 2018 Aug; 53(4):408-414. PubMed ID: 30119797
[TBL] [Abstract][Full Text] [Related]
13. OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND SURGICAL OUTCOMES OF TISSUE PLASMINOGEN ACTIVATOR-ASSISTED VITRECTOMY FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Hirashima T; Moriya T; Bun T; Utsumi T; Hirose M; Oh H
Retina; 2015 Oct; 35(10):1969-78. PubMed ID: 26079475
[TBL] [Abstract][Full Text] [Related]
14. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
Kishikova L; Saad AAA; Vaideanu-Collins D; Isac M; Hamada D; El-Haig WM
Eur J Ophthalmol; 2021 Sep; 31(5):2621-2624. PubMed ID: 32993349
[TBL] [Abstract][Full Text] [Related]
15. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
[TBL] [Abstract][Full Text] [Related]
16. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.
Patikulsila D; Winaikosol P; Choovuthayakorn J; Watanachai N; Chaikitmongkol V; Kunavisarut P
BMC Ophthalmol; 2022 Oct; 22(1):411. PubMed ID: 36303103
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
Barayev E; Tiosano A; Zlatkin R; Elul R; Dotan A; Hadayer A; Gal-Or O; Ehrlich R
Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
[TBL] [Abstract][Full Text] [Related]
19. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
Jackson TL; Bunce C; Desai R; Hillenkamp J; Lee CN; Lois N; Peto T; Reeves BC; Steel DH; Edwards RT; van Meurs JC; Wafa H; Wang Y
Trials; 2022 Jan; 23(1):99. PubMed ID: 35101110
[TBL] [Abstract][Full Text] [Related]
20. Displacement of Submacular Hemorrhage With Vitrectomy Combined With Subretinal Balanced Salt Solution and Air.
Handa S; Dogra M; Tigari B; Katoch D; Singh R
Retina; 2023 Dec; 43(12):2194-2198. PubMed ID: 37490775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
